Showing results (11-20 of 671) with videos related to
Sort By:
Pageof 68
Frontiers in Neurology|December 24, 2021
New Trends and Most Promising Therapeutic Strategies for Epilepsy TreatmentAntonella Riva, Alice Golda, Ganna Balagura, et al.Seizure|July 3, 2022
Phosphatase and tensin homolog (PTEN) variants and epilepsy: A multicenter case seriesNadia Ronzano, Marcello Scala, Emanuela Abiusi, et al.Frontiers in Neurology|May 18, 2026
Is cognitive profiling in NF1 still optional? A systematic review of current assessment practicesAndrea Santangelo, Alessandra Sardi, Luca Bergonzini, et al.Epilepsia Open|September 12, 2025
Long-term plasma monitoring of THC and CBD in pediatric drug-resistant epilepsy: Implications for cannabidiol therapy with Epidyolex®Alessia Cafaro, Antonella Riva, Federica Pigliasco, et al.Neurology. Clinical Practice|November 16, 2022
Pediatric SARS-CoV-2-Related Diplopia and Mesencephalic AbnormalitiesSara Signa, Noemi Brolatti, Chiara Trincianti, et al.Clinical Drug Investigation|October 29, 2015
Safety of Overnight Switch from Brand-Name to Generic LevetiracetamMaria Stella Vari, Francesca Pinto, Elisabetta Mencaroni, et al.European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|August 28, 2022
Electroencephalographic findings in ATRX syndrome: A new case series and review of literatureSalvatore Aiello, Maria Margherita Mancardi, Alfonso Romano, et al.Neurology. Clinical Practice|April 25, 2024
Early Developmental Intervention and Enriched Environment in CDKL5 Developmental and Epileptic Encephalopathy: A Case ReportMartina Giorgia Perinelli, Cecilia Naboni, Ganna Balagura, et al.Neurology and Therapy|February 11, 2016
Treatment of Adults with Lennox-Gastaut Syndrome: Further Analysis of Efficacy and Safety/Tolerability of RufinamideRob McMurray, Pasquale StrianoExpert Opinion on Investigational Drugs|November 27, 2009
New and investigational antiepileptic drugsPasquale Striano, Salvatore StrianoPageof 68